ClinicalTrials.Veeva

Menu

Validation of Chinese SRI Questionnaire (VCSRI)

G

Guangzhou Institute of Respiratory Disease

Status

Unknown

Conditions

Chronic Obstructive Pulmonary Disease
Hypercapnic Respiratory Failure

Study type

Observational

Funder types

Other

Identifiers

NCT02240225
GZIRD-20140910

Details and patient eligibility

About

Assessment of health-related quality of life in COPD patients with severe chronic respiratory failure requires appropriate and highly specific measurement tools. We attempt to validate the Chinese version of the Severe Respiratory Insufficiency Questionnaire (SRI)

Enrollment

150 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult COPD Patients with chronic hypercapnic respiratory failure established on home noninvasive ventilation for at least 1 month
  2. Patients are in a clinically stable state,without any changes of medication during the previous 4 weeks.

Exclusion criteria

  1. patient's refusal to participate
  2. Patients with evidence of acute respiratory failure i.e.patients with worsening of symptoms during the previous 2 weeks, a pH ,7.35, or with signs of respiratory infection

Trial contacts and locations

1

Loading...

Central trial contact

Zhou LuQian, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems